Cannabinoid Formula A Compounds Receptor Selectivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for cannabinoid compounds with strong CB1 or CB2 affinity, preferably with one affinity predominating over the other, for therapeutic applications such as appetite stimulation, antiemetic effects, pain relief, and immune stimulation, while also considering ecological advantages and using non-chlorine-containing solvents.
Innovation Solution
Development of specific cannabinoid compounds of formula (A) and their salts, which exhibit favorable binding affinity to CB1 and CB2 receptors, allowing for their use in pharmaceutical formulations and processes that prioritize CB2 receptor modulation, using non-chlorine solvents and improving yield efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cannabinoid compounds are developed for strong CB1 or CB2 affinity, then therapeutic effectiveness is improved, but selectivity between CB1 and CB2 receptors becomes difficult to achieve
Solution Approach 1:
The patent applies local quality by modifying specific functional groups at particular positions on the cannabinoid molecule. Compound I introduces a hydroxyl group at position 2 of the resorcinol ring, while Compound II modifies the alkylidene group at position 1. These localized structural changes create distinct binding characteristics that enable selective affinity for either CB1 or CB2 receptors, resolving the contradiction between overall effectiveness and receptor selectivity.
2Productivity
If traditional synthesis methods are used for cannabinoid compounds, then production is achieved, but environmental harm increases due to chlorine-containing solvents
Solution Approach 1:
The patent applies parameter changes by replacing the chemical composition parameter of the solvent system. The synthesis method substitutes chlorine-containing solvents (such as dichloromethane or chloroform) with non-chlorinated alternatives like ethyl acetate, methyl tert-butyl ether, or ethanol. This parameter change maintains the productivity of cannabinoid compound production while eliminating the harmful environmental effects associated with chlorine solvent disposal and degradation.
3Productivity
If high yields of cannabinoid compounds are produced, then economic benefit is improved, but process complexity increases
Solution Approach 1:
The patent applies preliminary action by performing protective group chemistry before the main synthesis steps. The methodology introduces protecting groups on functional groups that might interfere with subsequent reactions, ensuring high yields without requiring complex purification steps later. This preliminary preparation simplifies the overall process by preventing side reactions and eliminating the need for complex separation procedures, thus resolving the contradiction between yield efficiency and process complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds achieve desired therapeutic effects by selectively binding to CB1 and CB2 receptors, offering effective treatments for various medical conditions with improved ecological and economic benefits.
Implementation Method 1
The compounds achieve desired therapeutic effects by selectively binding to CB1 and CB2 receptors
Data Source
Figure 1
AI summary
Specific mixtures comprising one or more (cannabinoid) compounds of the formula (A) and/or one or more of the salts thereof are described, as are processes for preparation thereof. Also described are a compound of the formula (A), a salt of the formula (A) and a corresponding mixture for use as a medicament or for use in a method for therapeutic treatment of the human or animal body. Additionally described are corresponding pharmaceutical formulations, cosmetic formulations and formulations which are suitable for consumption and serve the purposes of pleasure and/or nutrition, and a process for preparation of delta-9-tetrahydrocannabinol.